Gabapentin
Product Images NDC 66116-358

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 66116-358). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Medvantx, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

562aa1bb-figure-01 (6b3ca748 7172 4c53 B5ae 7e17dad918eb 01)

Chemical structure of gabapentin showing a cyclohexane ring with aminomethyl (CH2NH2) and acetic acid (CH2CO2H) side groups attached to the same carbon.*

FDA Label Image

562aa1bb-figure-02 (6b3ca748 7172 4c53 B5ae 7e17dad918eb 02)

Line graph comparing mean pain scores over 8 weeks between placebo and Gabapentin 3600 mg/day groups. The x-axis shows weeks including a 4-week dose titration and a 4-week fixed-dose period. The y-axis represents mean pain scores, with Gabapentin showing a decrease compared to placebo.*

FDA Label Image

562aa1bb-figure-03 (6b3ca748 7172 4c53 B5ae 7e17dad918eb 03)

A line graph showing the mean pain score over seven weeks for three groups: Placebo, Gabapentin 1800 mg/day, and Gabapentin 2400 mg/day. The graph includes a 3-week dose titration period followed by a 4-week fixed dose period. Both gabapentin groups show a greater reduction in mean pain score compared to placebo, with statistical significance indicated (p < 0.01).*

FDA Label Image

562aa1bb-figure-04 (6b3ca748 7172 4c53 B5ae 7e17dad918eb 04)

A bar graph comparing the percentage of responders at endpoint in two studies for Gabapentin (GBP) at doses of 1800, 2400, and 3600, versus placebo (PBO). The y-axis shows percentage responding from 0 to 50%. Study 1 includes placebo (12%) and GBP 3600 (29%), Study 2 includes placebo (14%), GBP 1800 (32%), and GBP 2400 (34%). Statistical significance values (p < 0.01, p < 0.001) are noted above the bars.*

FDA Label Image

562aa1bb-figure-05 (6b3ca748 7172 4c53 B5ae 7e17dad918eb 05)

A scatter plot showing percentage difference on the y-axis and daily dose in mg on the x-axis. Data points are indicated for three studies labeled as study a, study b, and study c, with daily doses ranging approximately from 600 to 1800 mg. Each study's data points are plotted with different symbols showing variation in percentage difference across doses.*

FDA Label Image

562aa1bb-figure-06 (6b3ca748 7172 4c53 B5ae 7e17dad918eb 06)

Gabapentin 300 mg capsules by MedVantx, Inc. The front of a white and gray blister card featuring thirty capsules arranged in three rows of ten each. The capsules are white and maroon.*

FDA Label Image

562aa1bb-figure-07 (6b3ca748 7172 4c53 B5ae 7e17dad918eb 07)

Gabapentin 300 mg capsules bottle label from MedVantx, Inc. The label displays the proprietary name Gabapentin prominently, the strength of 300 mg, and indicates it contains capsules. The label includes the MedVantx, Inc. logo and product NDC 66116-358.*

FDA Label Image

562aa1bb-figure-08 (6b3ca748 7172 4c53 B5ae 7e17dad918eb 08)

Gabapentin 100 mg capsules by MedVantx, Inc. The white carton displays the product name, strength, and dosage form, with branding in blue and purple text. The package contains 100 capsules and features the NDC number 66116-358.*

FDA Label Image

Gabapentin 300mg Capsules (6b3ca748 7172 4c53 B5ae 7e17dad918eb 09)

Label for Gabapentin Capsules, USP 300 mg, containing 60 capsules. The label includes dosage instructions, with a note to see the package insert. It shows the product is prescription only and for sample use not for sale. The label indicates storage at controlled room temperature (20°-25°C). Manufactured by Actavis Elizabeth LLC and distributed by MedVantx, Inc., San Diego, CA. Contact phone number and website for MedVantx are also displayed.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.